Published in Chimia (Aarau) on May 15, 1948
Experiments on a new clotting factor (factor VII). Acta Haematol (1951) 3.08
Enzymes of starch degradation and synthesis. Adv Enzymol Relat Subj Biochem (1951) 2.71
The Stuart-Prower factor assay and its clinical significance. Thromb Diath Haemorrh (1958) 2.09
A hitherto undescribed congenital haemorrhagic diathesis probably due to fibrin stabilizing factor deficiency. Thromb Diath Haemorrh (1960) 2.01
[Factor VII; its role in coagulation; its clinical importance]. Rev Hematol (1952) 1.83
The influence of fibrin stabilizing factor on the growth of fibroblasts in vitro and wound healing. Thromb Diath Haemorrh (1961) 1.46
[The effect of the guide dusts on the phagocytosis of quartz]. Arch Hyg Bakteriol (1951) 1.43
ANTIGENS AND ENZYMES MADE INSOLUBLE BY ENTRAPPING THEM INTO LATTICES OF SYNTHETIC POLYMERS. Science (1963) 1.34
A coenzyme of spleen beta-glucuronidase. Science (1950) 1.28
Isolation of beta-glucuronidase of calf spleen. Arch Biochem (1950) 1.25
[A case of follicular trichophytia caused by Epidermophyton interdigitale Kaufmann-Wolff; Ctenomyces interdigitale]. Dermatologica (1953) 1.20
EFFECT OF SYNTHETIC AND BIOLOGICAL POLYANIONS ON HERPES SIMPLEX VIRUS. Proc Soc Exp Biol Med (1964) 1.20
Interaction of human serum beta-lipoglobulin with polyanions. J Biol Chem (1957) 1.20
Rare complication of phenytoin sodium treatment. Br Med J (1956) 1.13
The influence of tumor growth on the plasma proteins in mice. Cancer Res (1955) 1.11
Beta-glucuronidase. I. Purification of calf spleen beta-glucuronidase. J Biol Chem (1953) 1.09
Clotting factor X; physiologic and physico-chemical properties. Proc Soc Exp Biol Med (1955) 1.06
[Cystostatic ointments in local therapy of surface carcinoma and precancerous skin diseases]. Dermatologica (1956) 1.03
A modification of the thromboplastin generation test. Acta Haematol (1954) 1.03
[Not Available]. Helv Chim Acta (1948) 1.03
[Not Available]. Helv Chim Acta (1948) 1.00
Beta-Glucuronidase. II. Purification of calf liver beta-glucuronidase. J Biol Chem (1953) 0.99
Purification and physiological properties of factor VII from plasma and serum; separation from prothrombin. Proc Soc Exp Biol Med (1953) 0.98
Studies on the mechanical fragility of erythrocytes. I. Normal values for infants and children. Blood (1953) 0.96
[Present stand of antibiotic and chemotherapeutic treatment of venereal diseases]. Antibiot Chemother (1955) 0.96
INHIBITION OF FIBRINOLYSIS AND FIBRINOGENOLYSIS IN MAN: COMPARISON OF EPILSON-AMINOCAPROIC AID AND KALLIKREIN INHIBITOR. Thromb Diath Haemorrh (1963) 0.96
Abnormal plasma components in C3H mice bearing spontaneous tumors. Cancer Res (1960) 0.95
[Numerical frequency of various yeasts in mycological examination material]. Schweiz Z Pathol Bakteriol (1955) 0.94
[Not Available]. Dermatologica (1955) 0.92
[On the infectiosity of stockings and shoes of patients with foot mycoses]. Dermatologica (1951) 0.92
Inhibitory and activating effects of polyanions on lipoprotein lipase. J Biol Chem (1963) 0.92
Endometrial secretions. Ann N Y Acad Sci (1963) 0.91
[Congenital circinate dermatosis; Darier's type of eczematoid papulo-circinate migrating disease]. Dermatologica (1955) 0.90
Differentiation of the factor VII complex; studies on the Stuart-Prower factor. Thromb Diath Haemorrh (1957) 0.90
SMOKING BY HIGH SCHOOL STUDENTS. FAILURE OF A CAMPAIGN TO PERSUADE ADOLESCENTS NOT TO SMOKE. Calif Med (1964) 0.90
[The role of factor X in the formation of blood thromboplastin]. Rev Hematol (1954) 0.89
Characteristic electrophoretic patterns in hemophilia and idiopathic thrombocytopenia. Proc Soc Exp Biol Med (1951) 0.88
A simple nephelometric method for the determination of human serum betalipoprotein. J Clin Invest (1957) 0.86
[A new congenital coagulation defect; Stuart factor defect]. Thromb Diath Haemorrh (1958) 0.86
A bufotenin-like substance in the urine of schizophrenics. J Nerv Ment Dis (1961) 0.83
Plasma thromboplastin antecedent and the activation of factor IX. Thromb Diath Haemorrh (1960) 0.83
PROTEOLYSIS OF HUMAN SERUM BETA-LIPOPROTEIN. J Biol Chem (1964) 0.82
[Accessory free bone elements in the area of the foramen occipitale magnum]. Fortschr Geb Rontgenstr Nuklearmed (1959) 0.82
The prephase accelerator. Present status. Thromb Diath Haemorrh (1961) 0.82
[Frequency of skeletal growth inhibition after radiotherapy in hemangioma]. Strahlentherapie (1955) 0.82
[The use of aniline dyes in external eczema therapy]. Dermatologica (1955) 0.81
[PUNCTURE OF THE THORACIC DUCT AS A COMPLICATION IN TRANSLUMBAR AORTOGRAPHY]. Fortschr Geb Rontgenstr Nuklearmed (1965) 0.81
Vascular anomaly associated with plasma thromboplastin antecedent deficiency. J Lab Clin Med (1959) 0.80
[Analytic antigen and experimental animal studies on the mycology of micro-organisms causing interdigital mycoses]. Arch Klin Exp Dermatol (1956) 0.80
Effect of catecholamines on the psychomotor activity of mice. Nature (1962) 0.79
[Experimental pharmacological principles of griseofulvin therapy]. Dermatologica (1961) 0.79
[Calcification patterns of costal cartilages]. Fortschr Geb Rontgenstr (1955) 0.79
[The effect of plasmin (fibrinolysin) on blood coagulation factors]. Schweiz Med Wochenschr (1960) 0.79
[A new coagulation factor (factor 7) and its clinical significance]. Dtsch Med Wochenschr (1952) 0.79
[Joint-like cleavages within totally calcified costal cartilaged in adrenogenital syndrome]. Fortschr Geb Rontgenstr Nuklearmed (1956) 0.79
[Hoschek's rapid test for syphilis using chromotest]. Schweiz Med Wochenschr (1950) 0.79
The formation of intermediate product I in a purified system. The role of factor IX or its precursor and of a Hageman factor-PTA fraction. Thromb Diath Haemorrh (1961) 0.78
[Effect of perspiration and pH on the growth of skin-pathogenic fungi]. Dermatologica (1959) 0.78
Conversion of prothrombin to autoprothrombin II. Can J Biochem Physiol (1956) 0.78
Basic biological effects of ultrasonic energy. Am J Phys Med (1954) 0.78
[Trials for culture of verrucal virus on chorio-allantois of the hen's egg]. Arch Dermatol Syph (1953) 0.78
[Not Available]. Ergeb Physiol (1957) 0.78
Activator-competitive enzyme inhibition; interrelation of dissociation, activation, inhibition and surface inactivation of beta-glucuronidase. Arch Biochem Biophys (1957) 0.77
[Technic of identification of the yeast-like micro-organisms]. Schweiz Z Pathol Bakteriol (1953) 0.77
[The significance of factor X for anticoagulant therapy]. Schweiz Med Wochenschr (1954) 0.77
[Not Available]. Dermatologica (1955) 0.77
[Not Available]. Helv Chim Acta (1947) 0.77
[SUBDURAL HEMATOMA]. Schweiz Med Wochenschr (1964) 0.77
EFFECT OF METHYLAMPHETAMINE ON THE PSYCHOMOTOR DEPRESSION PRODUCED BY ADRENALINE IN MICE. Nature (1964) 0.76
Familial hypogonadal infantilism. J Ir Med Assoc (1957) 0.76
[A new familial coagulation disorder due to a deficiency of a fibrinstabilizing factor]. Schweiz Med Wochenschr (1961) 0.76
Isophosphorylase and the formation of branched polysaccharides. Nature (1948) 0.76
Birefringence and ultrastructure of muscle. Ann N Y Acad Sci (1947) 0.76
[Effect of chronic alcohol consumption on the child's development]. Arch Kinderheilkd (1950) 0.75
[COMBINED AHG- AND PTA-DEFICIENCY]. Thromb Diath Haemorrh (1964) 0.75
[A NEW TEST FOR THE DETERMINATION OF THE FIBRIN STABILIZING FACTOR (FSF)]. Schweiz Med Wochenschr (1963) 0.75
The effect of daily electrical stimulation of normal and denervated muscles upon their protein content and upon some of the physicochemical properties of the protein. Am J Physiol (1946) 0.75
Effect of hypotensive drugs and hypophysectomy upon the adrenal cortex of normal and hypertensive dogs. Ann Surg (1961) 0.75
Synergetic action of 2(o-methoxyphenoxymethyl)-5-oxazolidone on morphine, dihydrocodeine and aminopyrine analgesia. Nature (1960) 0.75
Effect of moderate and of weak ultrasonic exposures upon normal and denervated mammalian muscles. Am J Phys Med (1954) 0.75
Comparative bacteriostatic assays with rosaniline and its phenolic analog (rosolic acid). J Bacteriol (1947) 0.75
Changes in muscle proteins during atrophies of various types and the retardation of some of these changes by electrical treatment. Fed Proc (1946) 0.75
[Calcification of vertebral and bronchial cartilage in aged]. Z Alternsforsch (1954) 0.75
Chemical factors influencing muscular atrophy. Am J Physiol (1949) 0.75
On the activation of molecular hydrogen by Proteus vulgaris. J Biol Chem (1947) 0.75
About the chemical nature of syphilis antigen. Science (1946) 0.75
[Not Available]. Strahlentherapie (1947) 0.75
[Not Available]. Dtsch Tierarztl Wochenschr (1947) 0.75
[Effect of rectal administration of calcium on blood calcium level in rabbits]. Arzneimittelforschung (1954) 0.75
Electrophoresis of the water-soluble proteins of normal and atrophied muscles nontreated and treated by daily electrical stimulation. Arch Phys Med Rehabil (1949) 0.75
Relation between quinoid structure and bacteriostatic activity of tetramethyl-diaminodi-phenylmethane derivatives. J Bacteriol (1946) 0.75
[Not Available]. Helv Chim Acta (1948) 0.75
Adenosinetriphosphatase activity of myosin from denervated skeletal muscle. Fed Proc (1947) 0.75
Muscle strength and the weather. Arch Phys Med Rehabil (1947) 0.75
[Not Available]. Helv Chim Acta (1948) 0.75
Changes in zymohexase activity during denervation atrophy of skeletal muscle and their retardation by appropriate electrical treatment. Fed Proc (1948) 0.75
[Not Available]. Helv Chim Acta (1948) 0.75
Electrophoretic plasma protein patterns in families with hemophilia. Proc Soc Exp Biol Med (1953) 0.75
[On large parietal foramina]. Fortschr Geb Rontgenstr (1954) 0.75
Some enzyme systems of denervated muscle. Arch Phys Med Rehabil (1948) 0.75